Related Guide
Sleep Problems in Neurodivergent Children
Sleep and ADHD medication often interact. What to expect, and what you can try first.
If you're starting to wonder about medication for your child — what it is, how it works, what the options are — here's a plain-English guide. This isn't medical advice. It's the information I wish I'd had before my first appointment.
I'm a parent, not a doctor, pharmacist or mental health professional. This guide is a starting point only. It draws on publicly available information from NICE (National Institute for Health and Care Excellence), the NHS, peer-reviewed research published in The Lancet Psychiatry and the Journal of the American Academy of Child & Adolescent Psychiatry, and NHS shared-care protocols. It is not medical advice and must not be used to make any treatment decision. Please speak to your child's GP, paediatrician or ADHD specialist about any question you have. Never start, stop, or change a child's medication without medical supervision.
ADHD medication is one of the most searched and most anxiously discussed topics in SEN parent groups. Parents want to know what the options are. They want to know if it's safe. They want to know what it will do to their child. And they want to know what they should ask the doctor — because half an hour with a paediatrician, with a nervous child next to you, is rarely enough time to cover everything.
I can't tell you whether medication is right for your child. No one on the internet can. But I can put the information in one place — calmly, factually, and in plain English — so that when you do sit down with your doctor, you've got your bearings. That's all this is.
This is worth saying before anything else, because it gets lost in the noise.
NICE — the body that sets NHS treatment guidelines — is clear that ADHD medication is never the whole answer. Their guidance (NG87, the main UK clinical guideline on ADHD) recommends medication only as part of a wider treatment plan that also includes education about ADHD, parent and carer support, school-based adjustments, and — where relevant — psychological interventions. For children under 5, NICE does not recommend medication as a first-line treatment at all. Group-based parent-training is the starting point for that age group.
For children aged 5 and over, medication is recommended only when ADHD symptoms are still causing significant impairment in at least one area of daily life — home, school, friendships, self-esteem — despite environmental changes being in place. It's not a first resort. It's a tool considered when the other tools haven't been enough on their own.
Medication manages symptoms; it doesn't cure ADHD. The US ADHD organisation CHADD puts it well: ADHD medication is like glasses — it helps when it's working, but your child's underlying brain wiring is the same either way. The goal is usually to take some of the load off, so that therapy, parenting strategies and school support have a better chance of landing.
In the UK, ADHD medication for a child must be initiated by a specialist. That usually means:
Community or hospital-based paediatrician with ADHD expertise. Often the first specialist families see via the NHS pathway.
Based in Child and Adolescent Mental Health Services (CAMHS). More common where there are co-occurring mental health concerns.
Works within a CAMHS or paediatric team. Can initiate and titrate medication under the team's governance.
NHS-contracted providers such as Clinical Partners, Psicon, Psychiatry-UK. Still an NHS service — see below.
Your GP cannot start your child on ADHD medication directly. What they can do — and what very often happens — is take over the repeat prescribing once a specialist has found the right medication and dose, and your child is stable on it. This is called a shared care agreement, and NICE supports it as standard practice. It usually kicks in after at least 12 weeks of specialist-led dose finding, and the specialist stays involved for ongoing reviews.
Most families start with their GP, who refers to the local NHS paediatric or CAMHS team. Waiting lists for these teams in many parts of the UK are now measured in years rather than months, which is a significant part of why so many families have turned to NHS Right to Choose.
In England, patients have a legal right under NHS rules to choose which NHS-contracted provider they are referred to for most specialist assessments. Some Right to Choose providers can see children significantly faster than local CAMHS, while still being an NHS service — treatment is NHS-funded and prescriptions are NHS prescriptions at the normal prescription cost (or free if your child qualifies).
Waiting times vary and some local Integrated Care Boards (ICBs) have introduced restrictions on Right to Choose referrals. Before asking your GP for a referral, it's worth checking the current status — ADHD UK keeps an up-to-date list of providers and wait times, and also tracks which ICBs have introduced restrictions.
"When Jude was being assessed, I genuinely did not know any of this. I thought you went to the GP and the GP sorted it. It was a friend in a parent group who mentioned Right to Choose. I'm not recommending any one route — your local CAMHS may be the right fit — but knowing you have options changes how the conversation at the GP goes."
NICE requires a proper baseline assessment before any ADHD medication is prescribed. This isn't a formality — it's the safety net. Typically it includes:
Since September 2019, NICE no longer requires an ECG before starting ADHD medication unless there's something in the cardiovascular history or examination that flags it as necessary, or the child is taking another medication that poses increased cardiac risk. That was a change many parents found reassuring.
In the UK, five medications are licensed for treating ADHD in children and young people aged 6 to 17. They fall into two groups: stimulants and non-stimulants. Here's an overview of each. None of this is a substitute for your specialist's recommendation — it's background so you're not hearing the names for the first time in the appointment.
Stimulants work quickly (within 30 to 60 minutes of a dose) and are the most extensively researched ADHD medications. They work by increasing levels of dopamine and noradrenaline in parts of the brain involved in attention, impulse control and executive function. A major network meta-analysis published in The Lancet Psychiatry in 2018, which pooled data from over 130 randomised controlled trials, concluded that stimulants show a large effect on reducing core ADHD symptoms in children and adolescents, with methylphenidate recommended as the first pharmacological choice for this age group.
Common UK brand names: Ritalin, Concerta XL, Equasym XL, Medikinet, Xaggitin XL, Delmosart, Matoride XL
UK brand name: Elvanse
UK brand name: Amfexa
Non-stimulants are generally considered when stimulants haven't worked, have caused intolerable side effects, aren't clinically appropriate (for example because of certain heart conditions, tics, or significant anxiety), or where the family and specialist have good reason to avoid a controlled drug. They take longer to work — often several weeks — and are taken every day, including weekends and holidays. No medication breaks.
UK brand name: Strattera
UK brand name: Intuniv
Starting ADHD medication isn't like taking a paracetamol. There's no "correct dose for a 9-year-old" to reach for. Instead, the specialist uses a process called titration: starting at a low dose, increasing slowly over several weeks, and watching carefully for both benefit and side effects at each step. The aim is to find the lowest dose that gives meaningful improvement without causing unacceptable side effects.
The starting dose is deliberately conservative. For stimulants, dose changes are typically made around once a week; for non-stimulants, every 1 to 2 weeks. The specialist will ask you — and often your child's teacher — for feedback at each step.
A typical titration period is 4 to 6 weeks for stimulants, and up to 12 weeks for non-stimulants. Quick dose changes aren't safe — the body and brain need time to adjust, and side effects that seem alarming in week one often settle by week three.
Note what's changed and what hasn't: attention, emotional regulation, mood, sleep, appetite, physical complaints. Also record pulse and blood pressure if your specialist has asked for this. At each review you'll be asked specific questions, and it's easy to forget detail without written notes.
Most specialists will ask you to share a feedback form with your child's teacher. Their view of what school is like on medication matters — classroom behaviour is often where the clearest changes show up.
If the first dose or the first medication doesn't produce dramatic results, that's common. It's also common for a child not to respond well to the first medication and to do significantly better on a different one. Persistence through the titration phase matters.
Side effects are the single biggest concern parents raise — and rightly so. The most common ones, across the stimulant class, are well documented and largely manageable:
Very common. Often worst at the dose peak. Management: bigger breakfasts before the dose takes effect, calorie-dense evening meals when appetite returns, and keeping snacks calorie-rich rather than large in volume.
Stimulants can make falling asleep harder — though some children actually sleep better because their overactive thoughts settle. Management often involves the last dose timing and careful attention to the bedtime routine.
Often settles within the first two weeks. Taking the dose with food (unless the preparation specifically says not to) can help. Persistent headache should be raised with the specialist.
Typically small increases (stimulants) or decreases (guanfacine). NICE requires monitoring at every dose change and routinely thereafter. Normally not clinically significant, but not ignored.
As a stimulant dose wears off, some children become irritable, emotional, or hyper for a short period. If it's severe, it often means the dose, timing or formulation isn't quite right and needs adjusting.
Some children on stimulants show a small slowing of growth (both height and weight). NICE requires height and weight to be plotted at each review. If growth is meaningfully affected, specialists may consider planned medication breaks during school holidays.
For atomoxetine specifically, the product information and NICE guidance both flag a small increased risk of suicidal thoughts in children and young people — this is part of the formal conversation before starting it, and a reason for the careful review process in the first weeks. For guanfacine, sleepiness is common at the start and usually improves.
Serious side effects — chest pain, fainting, a suddenly racing or irregular heartbeat, suicidal thoughts, new or worsening tics, or a genuine change in personality — are not common, but if they happen they need medical attention the same day. NHS 111 or your specialist's emergency number is the route, not waiting for the next review.
This is, without exaggeration, the most common concern I see parents raise in Facebook groups, and it's the one that keeps people up at night. It deserves a proper answer rather than being tucked at the bottom of an FAQ.
The short version: properly titrated ADHD medication should not change your child's personality. If it is — if they seem flat, dulled, not themselves, or like their spark has gone — that is information, not an inevitability. It usually means something needs adjusting.
Clinicians often describe the goal of titration as finding the dose where a child can access themselves more easily — not the dose that makes them most compliant. Those are very different things, and it's worth understanding the distinction before you start.
The right dose tends to look like: your child can finish a task they started, sit through a meal, hear an instruction without it derailing the next ten minutes, manage frustration without it tipping into a meltdown. Crucially, their humour is still there. Their opinions are still there. Their interests, their stubbornness, the things that make them them — all still there. What's quieter is the noise around the edges.
The wrong dose — or the wrong medication for that particular child — tends to look different. The child is quieter, yes, but in a way that feels off. They stop initiating conversation. They seem less interested in things they used to love. They describe feeling "weird" or "not right". Teachers report a child who is compliant but subdued. Parents describe it as "the lights are on but nobody's home", or simply say "I miss them".
If this is what you're seeing, raise it with the specialist — don't wait. A dose that flattens a child is not a successful outcome. It may mean the dose is too high, it may mean the medication isn't the right match for their brain chemistry, or it may mean something else is going on (sleep, anxiety, food intake, co-occurring conditions). All of those are fixable, but only if the specialist knows.
A lot of what parents fear when they imagine "personality change" is being shaped by older imagery — of overmedicated children, of being "doped", of losing the child they know in exchange for one who's easier to manage. I understand this fear completely. It was genuinely the thing I was most afraid of.
Modern ADHD prescribing is — at its best — a long way from that image. The titration process is designed specifically to find the smallest amount of medication that does the needed job. Monitoring is structured so that side effects that matter to your child's sense of self (mood, engagement, spark) are specifically asked about, not brushed aside. And the conversation is meant to be collaborative: your child's view of whether they feel like themselves is part of the clinical picture, not a nice-to-have.
What many parents describe, once they hit the right dose, is something closer to relief than to loss. The constant battles reduce. Their child finishes homework and is proud of it. They sit through a birthday meal. They describe — sometimes for the first time — what it feels like to be able to just do a thing without the ten tabs in their head.
"The thing I was most afraid of was losing Jude. Not physically — the version of him I knew. The one who climbs on the furniture and makes up elaborate stories and argues about everything. I was absolutely terrified that a pill would take that away. What I've watched, actually, is the opposite. The furniture-climbing is still there. The stories are still there. The arguing is very much still there. What's different is that he can hear me the first time. He finishes his cereal. He doesn't disintegrate at 4pm on a Tuesday. He is more himself, not less."
If you're starting medication — or considering it — these are the specific things worth keeping an eye on, and worth raising with the specialist without waiting for the next scheduled review:
None of these mean medication is wrong for your child. They mean the current setup needs a conversation. Sometimes a small dose reduction is all it takes. Sometimes a switch to a different medication within the same class transforms things. Sometimes the issue turns out not to be the medication at all, but something else that became more visible once the ADHD noise quieted down. All of those are solvable.
Once your child is on a stable dose, monitoring doesn't stop. NICE and NHS shared-care protocols require, at a minimum:
A quick word on the ADHD medication supply situation. The UK has experienced ongoing supply shortages of several ADHD medications since 2023. The Department of Health and Social Care publishes updates via the NHS Specialist Pharmacy Service, and your specialist or pharmacist is the right person to ask about current availability. If a prescription can't be filled, don't panic — contact the prescriber, as switching between equivalent modified-release preparations needs specialist input to get right.
A significant number of children with ADHD also have autism, anxiety, tics, low mood, or other co-occurring conditions. This isn't a reason to avoid medication — it's a reason for the specialist to think carefully about which one. NICE notes specifically that:
For more on how sensory profiles change the picture, our guides on sensory overload and sleep in neurodivergent children may be useful context for conversations with the specialist.
If you take nothing else from this guide, take the idea that you're allowed to ask questions. Specialist appointments are often short, and parents come out realising there were six things they meant to raise. Here's a shortlist worth writing down before you go:
"Why is this medication being recommended for my child specifically, rather than one of the others?"
"What's the starting dose? How often will it be reviewed? What's the expected titration timeline?"
"What specific side effects should I look out for? What would make you want to know straight away rather than at the next review?"
"If I'm worried between appointments — who do I call? What's the out-of-hours route?"
"If this one doesn't help, what happens next? How many options are there before we'd be looking at a second opinion?"
"How will we measure whether this is working? Are there rating scales you'll use? Will the school be asked?"
"The most useful thing I've ever done in a medical appointment is bring a written list. Not a clever list — literally the six things I wanted to ask. Appointments go fast. Children get fidgety. Important questions evaporate. A list in my hand is the only reason I've ever come out feeling like I actually got what I needed."
This guide is the beginning, not the end. The most reliable UK sources to read next are:
There's a lot of noise online about ADHD medication. Some of it is alarming, some of it is evangelical, and almost none of it is personal to your child. Your paediatrician, your specialist, and your GP are the people who can answer the questions that actually matter for the child sitting next to you — their history, their co-occurring conditions, their specific sensory profile, the family's circumstances.
Medication might help your child enormously. It might not be right for them. It might be right for a year and not for the one after that. All of those are normal outcomes of a process that's meant to be reviewed, adjusted and revisited over time. The goal isn't to get your child onto medication — it's to work out, with a professional, what gives your child the best chance of thriving. Sometimes that includes medication. Sometimes it doesn't.
Whatever you decide together with your child's clinical team, the fact that you're researching, asking questions, and reading things like this guide matters. It means the decisions being made for your child are informed ones.
The questions parents raise most when thinking about medication — answered plainly, but not as medical advice.